Glow-Protocol, like other peptide-based formulations, is generally well tolerated in research settings but may present certain side effects depending on dosage and duration of use. Short-term effects can include mild skin flushing, headaches, fatigue, or localized irritation at the site of application. Some users report a temporary metallic or copper-like taste, which is linked to its active compounds. Medium-term use may cause shifts in collagen remodeling, sometimes leading to transient changes in skin texture before improvements appear. Long-term or excessive exposure carries the risk of copper–zinc imbalance, which can affect immunity, hair health, and wound healing. Continuous use without breaks may also reduce cellular responsiveness, so research protocols often recommend periodic washout phases. While these effects are typically reversible, Glow-Protocol is not FDA-approved for therapeutic use and should be handled strictly within controlled research environments.